P21 Research Peptide

Introduction to P21

P21 is an investigational synthetic neurotrophic peptide developed as a small peptide mimetic of Ciliary Neurotrophic Factor (CNTF). Designed to reproduce selected biological activities of CNTF while avoiding many of the pharmacokinetic limitations of the full-length protein, P21 has become an important experimental tool for researchers investigating neuroprotection, synaptic plasticity, neurogenesis, cognitive function, mitochondrial biology, and age-related neurodegeneration.

Unlike larger neurotrophic proteins, P21 is a short synthetic peptide engineered to penetrate neural tissue efficiently and stimulate intracellular pathways associated with neuronal survival and regeneration. Its ability to influence multiple aspects of neuronal biology has generated considerable interest in neuroscience, regenerative medicine, stem cell biology, and translational neurology.

P21 remains an investigational research compound and has not been approved for therapeutic or clinical use.

What is P21?

P21 is a synthetic peptide derived from a biologically active region of Ciliary Neurotrophic Factor (CNTF), a cytokine belonging to the interleukin-6 (IL-6) family of neurotrophic factors.

CNTF plays an essential role in:

• Neuronal survival
• Axonal maintenance
• Synaptic development
• Neural stem cell regulation
• Glial biology
• Neuroplasticity

Because native CNTF exhibits poor pharmacokinetic properties and limited blood-brain barrier penetration, investigators developed P21 to retain selected neurotrophic functions while improving stability and experimental utility.

Research has evaluated P21 in models involving:

• Alzheimer’s disease
• Age-related cognitive decline
• Neurodegeneration
• Traumatic brain injury
• Synaptic dysfunction
• Neurogenesis
• Learning and memory
• Mitochondrial dysfunction

Chemical Structure

Molecular Identity

Common Name: P21

Peptide Class: Synthetic Neurotrophic Peptide

Origin: CNTF-derived peptide mimetic

Chemical Type: Synthetic linear peptide

CAS Number

CAS Number: No universally recognized CAS registry number has been assigned for research-grade P21.

Some suppliers may use internal catalog identifiers, but there is currently no broadly recognized public CAS registration for this investigational peptide.

Chemical Structure

P21 is a short synthetic peptide engineered from an active region of CNTF. Unlike recombinant CNTF protein, P21 contains only the peptide sequence required to reproduce selected neurotrophic biological activity.

The precise amino acid sequence is proprietary or supplier dependent in many commercial preparations, and investigators should verify sequence information provided with the specific research material being used.

Proposed Mechanism of Action

Current research suggests P21 influences multiple intracellular pathways involved in neuronal survival and plasticity.

Neurotrophic Signaling

P21 has been investigated for its ability to activate pathways associated with:

• Neuronal survival
• Synaptic maintenance
• Axonal growth
• Cellular differentiation
• Neural repair

These effects are believed to mimic selected biological actions of endogenous CNTF.

Synaptic Plasticity

Experimental investigations have reported increased expression of proteins associated with:

• Synapse formation
• Synaptic density
• Dendritic spine maintenance
• Long-term potentiation

These observations have generated interest in learning and memory research.

Neurogenesis

Research suggests P21 may influence:

• Neural stem cell proliferation
• Neural progenitor differentiation
• Hippocampal neurogenesis
• Cellular maturation

These mechanisms continue to be actively investigated.

Mitochondrial Biology

Emerging evidence suggests P21 may support:

• Mitochondrial function
• Cellular bioenergetics
• ATP production
• Oxidative stress resistance
• Neuronal metabolic homeostasis

Additional studies are required to fully characterize these mechanisms.

P21 Research

Alzheimer’s Disease Research

P21 has received considerable attention in experimental Alzheimer’s disease models.

Published investigations have reported:

• Improved synaptic marker expression
• Increased neurogenesis
• Reduced neuronal loss
• Improved cognitive performance in animal models
• Preservation of hippocampal structure

These findings remain preclinical and require additional investigation.

Neurogenesis Research

Researchers continue to investigate P21’s effects on:

• Neural stem cells
• Adult hippocampal neurogenesis
• Neuronal differentiation
• Cellular maturation
• Brain plasticity

Synaptic Biology

Experimental studies have explored P21’s influence on:

• Synaptophysin expression
• PSD-95 expression
• Synaptic connectivity
• Dendritic spine density
• Long-term potentiation

Understanding these pathways may improve knowledge of learning and memory biology.

Neuroprotection

P21 has been investigated in laboratory models involving:

• Oxidative stress
• Excitotoxicity
• Neuroinflammation
• Protein aggregation
• Cellular stress responses

Researchers continue evaluating its effects on neuronal resilience.

Mitochondrial Function

Current investigations include:

• ATP generation
• Oxidative phosphorylation
• Mitochondrial integrity
• Reactive oxygen species
• Cellular energy metabolism

Because neuronal function is highly dependent upon mitochondrial health, these pathways remain an important area of research.

Potential In Vitro Research Applications

Research-grade P21 may be utilized in laboratory investigations involving:

• Primary neuronal cultures
• Neural stem cell culture
• Hippocampal neuron models
• Alzheimer’s disease models
• Synaptic plasticity assays
• Neurite outgrowth studies
• Neurogenesis assays
• Mitochondrial function analysis
• Oxidative stress experiments
• Gene expression profiling
• Protein expression analysis
• Brain organoid research
• Neurodegenerative disease models

Future Research Directions

Current investigations continue to explore:

Neurodegenerative Diseases

Evaluating P21 in models of:

• Alzheimer’s disease
• Parkinson’s disease
• Huntington’s disease
• Amyotrophic lateral sclerosis (ALS)

Cognitive Aging

Researchers continue investigating mechanisms involved in:

• Age-related memory decline
• Synaptic maintenance
• Neuroplasticity
• Hippocampal regeneration

Regenerative Neuroscience

Future investigations may evaluate P21 in:

• Neural tissue engineering
• Stem cell biology
• Brain repair
• Neural regeneration

Combination Neurotrophic Therapy

Researchers are exploring potential interactions between P21 and other investigational neurotrophic compounds including:

• Cerebrolysin
• Cerebroprotein hydrolysate
• Dihexa
• Semax
• Adamax
• BDNF-modulating therapies

Systems Biology

Modern transcriptomic, proteomic, metabolomic, and single-cell sequencing technologies may provide greater insight into P21-mediated signaling networks and neuronal adaptation.

Product Specifications

Product Name: P21

Peptide Class: Synthetic Neurotrophic Research Peptide

Origin: CNTF-derived peptide mimetic

CAS Number: No universally assigned CAS registry number

Research Classification: Experimental Neuroscience Research Peptide

Intended Use: In vitro laboratory research only

Scientific Summary

P21 is an investigational synthetic peptide designed to mimic selected biological activities of Ciliary Neurotrophic Factor (CNTF). Published preclinical studies have demonstrated promising effects on neurogenesis, synaptic plasticity, neuronal survival, and cognitive function in experimental models. Ongoing research continues to investigate its role in neurodegeneration, mitochondrial biology, regenerative neuroscience, and molecular mechanisms underlying neuronal repair.

References

1. Blanchard J, et al. Beneficial Effects of a CNTF Peptide Mimetic (P21) in an Alzheimer’s Disease Mouse Model. Neurobiology of Aging.
   https://pubmed.ncbi.nlm.nih.gov/?term=P21+CNTF+Alzheimer
2. National Center for Biotechnology Information. P21 CNTF peptide publications.
   https://pubmed.ncbi.nlm.nih.gov/?term=P21+CNTF+peptide
3. National Center for Biotechnology Information. PMC Archive – P21 Neurogenesis Research.
   https://pmc.ncbi.nlm.nih.gov/?term=P21+CNTF
4. Sendtner M, et al. Ciliary Neurotrophic Factor Biology and Mechanisms.
   https://pubmed.ncbi.nlm.nih.gov/?term=Ciliary+Neurotrophic+Factor
5. Ip NY, Yancopoulos GD. Neurotrophic Factors in the Nervous System. Annual Review of Neuroscience.
   https://www.annualreviews.org
6. National Institute on Aging. Alzheimer’s Disease Research Resources.
   https://www.nia.nih.gov/research

Disclaimer

This information is provided solely for research and educational purposes. P21 is not approved by the United States Food and Drug Administration (FDA) or any other regulatory authority for human or veterinary use. P21 is intended exclusively for in vitro studies, laboratory research, analytical testing, and experimental applications conducted by qualified researchers.

P21 is not intended for human consumption, clinical use, therapeutic use, veterinary use, or diagnostic applications. Researchers are solely responsible for ensuring compliance with all applicable laws, regulations, and institutional guidelines governing the purchase, handling, storage, and use of research materials.